American Express Co. buy BiotechBee
Start price
17.09.23
/
70%
€153.05
Target price
31.01.26
€200.00
Performance (%)
3.92%
End price
02.12.23
€159.05
Summary
This prediction ended on 02.12.23 with a price of €159.05. With a performance of 3.92%, the BUY prediction by BiotechBee for American Express Co. closed with a slight gain. Dividends of €0.57 are taken into consideration when calculating the performance. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| American Express Co. | 0.037% | 0.037% | 9.949% |
| iShares Core DAX® | 1.598% | 5.040% | 3.870% |
| iShares Nasdaq 100 | 3.742% | 14.947% | 36.139% |
| iShares Nikkei 225® | 3.736% | 13.892% | 43.808% |
| iShares S&P 500 | 1.816% | 8.879% | 25.510% |
According to BiotechBee what are the pros and cons of American Express Co. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread American Express Co. diskutieren
Buy mit Kursziel 200,0